Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Cash & Equivalents (2024 - 2026)

Updated

Drugs Made In America Acquisition's Cash & Equivalents was $174,974 in Q2 2026.

Analysis

Drugs Made In America Acquisition (DMII) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Drugs Made In America Acquisition came in at $223.00, down 98.7% from FY2024.

  • In earlier years, Cash & Equivalents was $17,035 in FY2024.
  • Quarterly Cash & Equivalents has moved between $223.00 (Q4 2025) and $315,087 (Q3 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 10.49 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 2.51 Bn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 760.00 Mn
5 Kkr 81.05 Bn 47.53 Bn - 21.08 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 1.50 Bn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 26.82 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 100.19 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 1.01 Bn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - 174,974.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 174,974.00
Dec 31, 2025 223.00
Sep 30, 2025 315,087.00
Dec 31, 2024 17,035.00
API Access

Drugs Made In America Acquisition Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DMII&period=max&api_key=YOUR_API_KEY